API Webinar💊 Q&A with @unseenvalue

Sir Promised 30 mins but ended up giving all of us more than 90 minutes 😁🙏

For unparalleled insights on the API industry🎥

https://t.co/x1U430JKFG

The Basics of a Cash Flow Statement explained from scratch 🏧🎰🧮

In this thread we will talk about -

1. How Cash flow statement is made?
2. What is CFO,CFI and CFF?
3. Why is CFO/Ebitda important?
4. Finally, we will talk about Free Cash flow statement

Retweet for max reach!

A Cash flow statement shows inflow and outflow of cash and cash equivalents from various activities of a company during a particular period.

The net cash flow at the end of the year tells us about the movement of cash on the balance sheet.

Why is cash flow important? ⤵️

Companies maintain books of accounts as per accrual principle, that means we book revenue or expense as and when it is incurred.

Let's say we make sales of 10,000 so we will record it as when sale is completed and prepare P&L accordingly, here it doesn't matter whether cash is received or not.

Cash flow helps us in knowing whether that 10,000 has been received in cash or not.

For Example:- There are 2 companies selling T-shirts and doing the following transactions:

Why Reading and observing different trends matter.

Time for a thread with a live example that is playing out in front of us! 🎵🎵

🧵🧵🧵🧵🧵

“What is elementary, worldly wisdom? Well, the first rule is that you can’t really know anything if you just remember isolated facts and try and bang ‘em back. If the facts don’t hang together on a latticework of theory, you don’t have them in a usable form.”- Charlie Munger

Charlie Munger who is the partner of Warren Buffett, has over the years explained the importance of creating a latticework of mental models. That is basically combining theory with live practical examples

One of the most interesting mental models he talked about in his books was that of Autocatalysis (lets understand this and how we can apply it to a live example):

"Disney is an amazing example of autocatalysis. They had all those movies in the can.

They owned the copyright. And just as Coke could prosper while refrigeration came, When the video cassette was invented, Disney didn’t have to invent anything or do anything except take the thing out of the can and stick it on the cassette.

The Art of asking smart questions | When do you really graduate as an investor?

Time for a thread🧵🧵🧵🧵🧵

Retweet for Max reach!!

You graduate as an investor when you start asking things like the quality of revenue, incremental quality of earnings and the competitive landscape. Eg:- One API player will grow earnings because of shortage in market for those

APIs but the other one which will grow because of being the lowest cost producer. The markets often give higher Valuations to the latter player.

Another example that comes to mind is Balkrishna Industries vs other tyre players.🚜🚜

Given the fact that it is the lowest cost producer and has the highest margins. It always gets a premium to the other players in the tyre space. Whether at peak or at trough.

One more example is that of APL Apollo, same business got low valuations during the last cycle and collapsed by 50%+ when their EBITDA per tonne reduced. In this cycle, the value added proportion has increased.

An Example of what Tailwinds look like:

Why Indoco Remedies looks Interesting and why FY22-24 growth is likely to be stellar here?

Time for a thread🧵🧵🧵🧵

(Source for ophthalmics data:Nirmal Bang and rest is own work)

Looking at the incremental opportunity in Ophthalmics:-

Market size is not attractive for the Large Generic companies but for someone like Indoco which has a smalll base in exports business

As per the USFDA’s orange book, for Ophthalmic suspension drugs, only 3 out of 17 molecules have an active patent. Among the 14 molecules that are patent expired, 8 molecules are yet to see generic
competition.

Even for the one’s which have seen generic competition, the competitive intensity is very low and there is space for an additional entrant.. Entrenched players like Novartis, Bausch & Lomb and Abbvie have dominated this market with legacy products for decades.

Indoco Remedies and Sun Pharma are the only Indian generic manufacturers to have successfully won approvals for generic version of Ophthalmic suspensions in the US market. Indoco Remedies has recently launched generic version of Azopt (brinozolamide)

Competence is something that sets investors apart!

Join @vivbajaj and Sajal Kapoor and learn the importance and LEARN HOW: https://t.co/NguCUN2WWl

#investing #investments #stockmarketindia #stockmarketeducation #nifty

Paraphrasing @tusharbohra on @IIC_Conference today ::

"If 10 commodity companies are doing capex at the same time, it signals a peak. If 10 companies in Chemicals/API/Pharma are doing capex in different products at the same time - it probably signals the start of a New Era" 🇮🇳🇮🇳

Biosciences is the space to track and follow globally. Sector offers extra large opportunity landscape. Shared the full thesis in that April webinar. Convinced that 🧬 will throw many big compounders in next few years.

#Fermentation #Biotechnology